Table of Contents:
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary Research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Challenges
4.5 Macroeconomic Indicators
4.6 Technology Trends & Assessment
Chapter 5. Market Factor Analysis
5.1 Porterโs Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
5.3 Investment Feasibility Analysis
5.4 Pricing Analysis
Chapter 6. Global Pemphigus Market, by Pemphigus Types
6.1 Introduction
6.2 Pemphigus Vulgaris
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.3 Pemphigus Foliaceus
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.4 Pemphigus Vegetans
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
6.5 Paraneoplastic Pemphigus
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
Chapter 7. Global Pemphigus Market, by Diagnosis
7.1 Introduction
7.2 Skin Peeling
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.3 Skin Biopsy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.4 Run Blood Tests
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
7.5 Endoscopy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
Chapter 8. Global Pemphigus Market, by Treatment
8.1 Introduction
8.2 Corticosteroids
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.3 Initial Therapy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.4 Maintenance Therapy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.5 Immunosuppressants
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.6 Biological Therapies
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.7 Intravenous Immunoglobulin (IVIG) Therapy
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
8.8 Other medication
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
Chapter 9. Global Pemphigus Market, by End User
9.1 Introduction
9.2 Laboratories
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9.3 Hospitals and Clinics
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
9.4 Academic and Research Institutes
Market Estimates & Forecast, by Region, 2020โ2027
Market Estimates & Forecast, by Country, 2020โ2027
Chapter 10. Global Pemphigus Market, by Region
10.1 Introduction
10.2 Americas
10.2.1 North America
10.2.1.1 US
10.2.1.2 Canada
10.2.2 South America
10.3 Europe
10.3.1 Western Europe
10.3.1.1 Germany
10.3.1.2 France
10.3.1.3 Italy
10.3.1.4 Spain
10.3.1.5 UK
10.3.1.6 Rest of Western Europe
10.3.2 Eastern Europe
10.4 Asia-Pacific
10.4.1 Japan
10.4.2 China
10.4.3 India
10.4.4 Australia
10.4.5 South Korea
10.4.6 Rest of Asia-Pacific
10.5 Middle East & Africa
10.5.1 Middle East
10.5.2 Africa
Chapter 11. Company Landscape
11.1 Introduction
11.2 Market Share Analysis
11.3 Key Development & Strategies
Chapter 12. Company Profiles
12.1 Novartis Pharmaceuticals
12.1.1 Company Overview
12.1.2 Product Overview
12.1.3 Financials Overview
12.1.4 Key Developments
12.1.5 SWOT Analysis
12.2 Hoffmann-La Roche
12.2.1 Company Overview
12.2.2 Product Overview
12.2.3 Financial Overview
12.2.4 Key Developments
12.2.5 SWOT Analysis
12.3 Principia Biopharma, Inc
12.3.1 Company Overview
12.3.2 Product Overview
12.3.3 Financial Overview
12.3.4 Key Development
12.3.5 SWOT Analysis
12.4 Argenx
12.4.1 Company Overview
12.4.2 Product Overview
12.4.3 Financial Overview
12.4.4 Key Development
12.4.5 SWOT Analysis
12.5 Sanofi S.A.
12.5.1 Company Overview
12.5.2 Product Overview
12.5.3 Financial overview
12.5.4 Key Developments
12.5.5 SWOT Analysis
12.6 Pfizer Inc
12.6.1 Company Overview
12.6.2 Product Overview
12.6.3 Financial Overview
12.6.4 Key Developments
12.6.5 SWOT Analysis
12.7 Teligent Inc
12.7.1 Overview
12.7.2 Product Overview
12.7.3 Financial Overview
12.7.4 Key Developments
12.7.5 SWOT Analysis
12.8 GlaxoSmithKline LLC
12.8.1 Overview
12.8.2 Product Overview
12.8.3 Financials
12.8.4 Key Developments
12.8.5 SWOT Analysis
12.9 Teva Pharmaceutical Industries
12.9.1 Overview
12.9.2 Product Overview
12.9.3 Financials
12.9.4 Key Developments
12.9.5 SWOT Analysis
Chapter 13 MRFR Conclusion
13.1 Key Findings
13.1.1 From CEOโs Viewpoint
13.1.2 Unmet Needs of the Market
13.2 Key Companies to Watch
13.3 Predictions for the Pemphigus Industry
Chapter 14. Appendix
LIST OF TABLES
Table 1 Global Pemphigus Market Synopsis, 2020โ2027
Table 2 Global Pemphigus Market Estimates and Forecast, 2020โ2027
(USD Million)
Table 3 Global Pemphigus Market, by Region, 2020โ2027 (USD Million)
Table 4 Global Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD Million)
Table 5 Global Pemphigus Market, by Diagnosis, 2020โ2027(USD Million)
Table 6 Global Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 7 Global Pemphigus Market, by End User, 2020โ2027 (USD Million)
Table 8 North America: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD
Million)
Table 9 North America: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 10 North America: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 11 North America: Pemphigus Market, by End-User, 2020โ2027 (USD Million)
Table 12 US: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD Million)
Table 13 US: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 14 US: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 15 US: Pemphigus Market, by End User, 2020โ2027 (USD Million)
Table 16 Canada: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD Million)
Table 17 Canada: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 18 Canada: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 19 Canada: Pemphigus Market, by End-User, 2020โ2027 (USD Million)
Table 20 South America: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD
Million)
Table 21 South America: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 22 South America: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 23 South America: Pemphigus Market, by End-User, 2020โ2027 (USD Million)
Table 24 Europe: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD Million)
Table 25 Europe: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 26 Europe: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 27 Europe: Pemphigus Market, by End-User, 2020โ2027 (USD Million)
Table 28 Western Europe: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD
Million)
Table 29 Western Europe: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 30 Western Europe: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 31 Western Europe: Pemphigus Market, by End-User, 2020โ2027 (USD Million)
Table 32 Eastern Europe: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD
Million)
Table 33 Eastern Europe: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 34 Eastern Europe: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 35 Eastern Europe: Pemphigus Market, by End-User, 2020โ2027(USD Million)
Table 36 Asia-Pacific: Pemphigus Market, by Pemphigus Types, 2020โ2027 (USD
Million)
Table 37 Asia-Pacific: Pemphigus Market, by Diagnosis, 2020โ2027 (USD Million)
Table 38 Asia-Pacific: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 39 Asia-Pacific: Pemphigus Market, by End-User, 2020โ2027 (USD Million)
Table 40 Middle East & Africa: Pemphigus Market, by Pemphigus Types, 2020โ2027
(USD Million)
Table 41 Middle East & Africa: Pemphigus Market, by Technology, 2020โ2027 (USD Million)
Table 42 Middle East & Africa: Pemphigus Market, by Treatment, 2020โ2027 (USD Million)
Table 43 Middle East & Africa: Pemphigus Market, by End-User, 2020โ2027 (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation for Global Pemphigus Market
Figure 3 Segmentation Market Dynamics for Global Pemphigus Market
Figure 4 Global Pemphigus Market Share, By Pemphigus Types, 2020
Figure 5 Global Pemphigus Market Share, By Diagnosis, 2020
Figure 6 Global Pemphigus Market Share, By Treatment, 2020
Figure 7 Global Pemphigus Market Share, By End User, 2020
Figure 8 Global Pemphigus Market Share, By Region, 2020
Figure 9 North America: Pemphigus Market Share, By Country, 2020
Figure 10 Europe: Pemphigus Market Share, By Country, 2020
Figure 11 Asia-Pacific: Pemphigus Market Share, By Country, 2020
Figure 12 Middle East & Africa: Pemphigus Market Share, By Country, 2020
Figure 13 Global Pemphigus Market: Company Share Analysis, 2020 (%)
Figure 14 Novartis Pharmaceuticals.: Key Financials
Figure 15 Novartis Pharmaceuticals.: Segmental Revenue
Figure 16 Novartis Pharmaceuticals.: Geographical Revenue
Figure 17 Hoffmann-La Roche.: Key Financials
Figure 18 Hoffmann-La Roche.: Segmental Revenue
Figure 19 Hoffmann-La Roche.: Geographical Revenue
Figure 20 Principia Biopharma, Inc.: Key Financials
Figure 21 Principia Biopharma, Inc.: Segmental Revenue
Figure 22 Principia Biopharma, Inc.: Geographical Revenue
Figure 23 Argenx: Key Financials
Figure 24 Argenx: Segmental Revenue
Figure 25 Argenx: Geographical Revenue
Figure 26 Sanofi S.A.: Key Financials
Figure 27 Sanofi S.A.: Segmental Revenue
Figure 28 Sanofi S.A.: Geographical Revenue
Figure 29 Pfizer Inc: Key Financials
Figure 30 Pfizer Inc: Segmental Revenue
Figure 31 Pfizer Inc: Geographical Revenue
Figure 32 Teligent Inc: Key Financials
Figure 33 Teligent Inc: Segmental Revenue
Figure 34 Teligent Inc: Geographical Revenue
Figure 35 GlaxoSmithKline LLC: Key Financials
Figure 36 GlaxoSmithKline LLC: Segmental Revenue
Figure 37 GlaxoSmithKline LLC: Geographical Revenue
Figure 38 Teva Pharmaceutical Industries.: Key Financials
Figure 39 Teva Pharmaceutical Industries.: Segmental Revenue
Figure 40 Teva Pharmaceutical Industries.: Geographical Revenue